CIPO Patents = 1

EPO Patents = 2

Forward Citations = 45

Loading Chart...

4 inventors (with patents filed for the assignee):

Charles D Smith (5 out of 25 patents)

Yan Zhuang (5 out of 5 patents)

Kevin J French (4 out of 6 patents)

4. Lynn W Maines (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. RE49811 - Sphingosine kinase inhibitors (2024-01-23),

2. 8685936 - Sphingosine kinase inhibitor prodrugs (2014-04-01),

3. 8557800 - Sphingosine kinase inhibitors (2013-10-15),

4. 8063248 - Sphingosine kinase inhibitors (2011-11-22),

5. 7338961 - Sphingosine kinase inhibitors (2008-03-04),

Apogee Biotechnology Corporation is a leading biotechnology company focused on developing novel therapies for cancer and other diseases. With a commitment to scientific excellence and innovation, Apogee is dedicated to improving patient outcomes through the discovery and development of cutting-edge treatments. The company's pipeline includes several promising drug candidates in preclinical and clinical development, targeting a range of oncology indications. Visit our website to learn more about our mission and research programs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

5 Patents

#3 in Hershey, PA

#1,867 in Pennsylvania

#51,508 in US

Hershey, PA, United States of America

Apogee Biotechnology Corporation

Forward Citations = 45

4 inventors:

Charles D Smith (5 out of 25 patents)

Yan Zhuang (5 out of 5 patents)

Kevin J French (4 out of 6 patents)

4. Lynn W Maines (1 out of 2 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]